A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA
NCT00958126
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1313
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
CSL425
BIOLOGICAL:
CSL425
BIOLOGICAL:
Placebo
Sponsor
Seqirus